# Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

> **NCT03942354** · — · COMPLETED · sponsor: **Medecins Sans Frontieres, Netherlands** · enrollment: 137 (actual)

## Conditions studied

- Multidrug Resistant Tuberculosis

## Interventions

- **DRUG:** Bedaquiline
- **DRUG:** Pretomanid
- **DRUG:** Moxifloxacin
- **DRUG:** Linezolid
- **DRUG:** Clofazimine
- **DRUG:** Directly observed therapy (DOT)

## Key facts

- **NCT ID:** NCT03942354
- **Lead sponsor:** Medecins Sans Frontieres, Netherlands
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2022-05-10
- **Final completion:** 2022-05-10
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2024-05-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03942354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03942354, "Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03942354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*